{"id":152648,"date":"2021-04-30T06:23:58","date_gmt":"2021-04-30T06:23:58","guid":{"rendered":"https:\/\/www.csoftintl.com\/?p=152648"},"modified":"2021-04-30T06:27:42","modified_gmt":"2021-04-30T06:27:42","slug":"csoft-ceo-shunee-yee-appointed-co-chair-of-a-taste-of-ginger-for-joslin-diabetes-center","status":"publish","type":"post","link":"https:\/\/www.csoftintl.com\/cn\/news-events\/csoft-ceo-shunee-yee-appointed-co-chair-of-a-taste-of-ginger-for-joslin-diabetes-center\/","title":{"rendered":"CSOFT CEO Shunee Yee Appointed Co-Chair of A Taste of Ginger for Joslin Diabetes Center"},"content":{"rendered":"\n<p>BOSTON,&nbsp;April 29, 2021&nbsp;\/PRNewswire\/ &#8212;&nbsp;CSOFT Health Sciences, leaders in medical translation and market access consulting, announced today that CSOFT Founder and CEO Ms.&nbsp;Shunee Yee&nbsp;will serve as co-chair of A Taste of Ginger, an event hosted by Joslin Diabetes Center, the world&#8217;s leading diabetes care and research center.&nbsp;Shunee Yee&#8217;s&nbsp;appointment extends CSOFT Health Sciences&#8217; support of multilingual communication solutions to promote patient diversity in advanced clinical trials and patient-centric care across the medical and pharmaceutical industry.<\/p>\n\n\n\n<p>As an independent, non-profit institution affiliated with&nbsp;Harvard Medical School, Joslin Diabetes Center established A Taste of Ginger in 2005 to promote awareness and raise funds for inclusive diabetes care and education, community outreach, and research programs.<\/p>\n\n\n\n<p>Approximately 422 million people across the globe, including 34 million in&nbsp;the United States, have been diagnosed with diabetes. &#8220;Asian populations generally develop diabetes at a lower Body Mass Index (BMI), and as a result, 51% of Asian Americans with diabetes remain undetected, thus patient-centric care must start from the beginning, in the clinical trial process,&#8221; said Dr. George L King. As the Chief Scientific Officer at Joslin Diabetes Center, Founder and Director of the Asian American Diabetes Initiative (AADI), and Professor of Medicine and Ophthalmology at&nbsp;Harvard Medical School, Dr. King&#8217;s renowned research on the complications of diabetes and guidance on successfully managing diabetes during the current health crisis has been highly informative.<\/p>\n\n\n\n<p>As 30-40% of those hospitalized due to COVID-19 have diabetes,&nbsp;Shunee Yee&#8217;s&nbsp;appointment to Co-Chair of this important fundraising event will serve as further support for Joslin&#8217;s mission for promoting health equity, and patient diversity in both clinical studies and clinical trials. &#8220;I am deeply honored to be appointed co-chair of A Taste of Ginger.&#8221; said&nbsp;Ms. Yee. &#8220;Diabetes is truly a global disease, disproportionately impacting Asian populations, so the research by the Joslin Center and the AADI is essential for raising awareness for diabetes and promoting equitable health across the globe.&#8221;&nbsp;<\/p>\n\n\n\n<p>To learn more about&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3145569-1&amp;h=1552724433&amp;u=https%3A%2F%2Fwww.joslin.org%2Fpatient-care%2Fmulticultural-programs%2Fasian-american-diabetes-initiative%2Ftaste-ginger&amp;a=A+Taste+of+Ginger\" rel=\"noreferrer noopener\" target=\"_blank\">A Taste of Ginger<\/a>&nbsp;or if you are interested in purchasing tickets to attend the event on&nbsp;May 16, visit&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3145569-1&amp;h=4085120203&amp;u=http%3A%2F%2Fwww.joslin.org%2Fginger&amp;a=www.joslin.org%2Fginger\" rel=\"noreferrer noopener\" target=\"_blank\">www.joslin.org\/ginger<\/a>.<\/p>\n\n\n\n<p>CSOFT Health Sciences further renews its support for patient diversity in its upcoming&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3145569-1&amp;h=2011986349&amp;u=https%3A%2F%2Fxtalks.com%2Fwebinars%2Flinguistic-validation-facilitating-patient-diversity-in-clinical-trials%2F&amp;a=webinar\" rel=\"noreferrer noopener\" target=\"_blank\">webinar<\/a>&nbsp;on Linguistic Validation: Facilitating Patient Diversity in Clinical Trials, hosted by Xtalks on&nbsp;May 7th&nbsp;at&nbsp;12pm EST, as it explores the importance of gaining a deeper understanding of the patient experience at the clinical trial stage. To learn more about CSOFT Health Sciences services, please visit:&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3145569-1&amp;h=3196675782&amp;u=https%3A%2F%2Flifesciences.csoftintl.com%2F&amp;a=https%3A%2F%2Flifesciences.csoftintl.com%2F\" rel=\"noreferrer noopener\" target=\"_blank\">https:\/\/lifesciences.csoftintl.com\/<\/a><\/p>\n\n\n\n<p>Media Contacts:<br>Nikki Andrews&nbsp;(U.S.\/Europe)<br>+1 (617) 263-8950<br><a href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x6e;&#105;&#107;k&#x69;&#x2e;&#x61;&#110;&#100;r&#x65;&#x77;&#x73;&#64;&#99;s&#x6f;&#x66;&#x74;&#105;nt&#x6c;&#x2e;&#x63;&#111;m\" target=\"_blank\" rel=\"noreferrer noopener\">&#x6e;&#105;k&#x6b;&#105;&#46;&#x61;&#110;d&#x72;&#101;w&#x73;&#64;c&#x73;&#111;f&#x74;&#105;n&#x74;&#108;&#46;&#x63;&#111;m<\/a><\/p>\n\n\n\n<p>Tim Wang&nbsp;(Asia)<br>+86 21 5036 7600<br><a href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x74;&#x69;m&#46;&#119;&#97;&#110;&#x67;&#x40;&#x63;&#x73;of&#116;&#105;&#110;&#x74;&#x6c;&#x2e;&#x63;om\" target=\"_blank\" rel=\"noreferrer noopener\">&#116;&#x69;&#109;&#x2e;&#119;&#x61;&#110;&#x67;&#64;&#x63;&#115;&#x6f;&#102;&#x74;&#105;&#x6e;&#116;&#x6c;&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h4>About CSOFT Health Sciences<\/h4>\n\n\n\n<p>CSOFT Health Sciences provides end-to-end medical translation services for all phases of the product lifecycle, from pre-clinical to post-launch. We also specialize in market access consulting, medical writing, and CTD\/eCTD submissions with the FDA, EMA, and NMPA. Our operations are compliant with ISO 17100 and certified in ISO 9001:2015 and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of global submissions.&nbsp;Learn more <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2842249-1&amp;h=532735112&amp;u=https%3A%2F%2Flifesciences.csoftintl.com%2F&amp;a=here\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON,&nbsp;April 29, 2021&nbsp;\/PRNewswire\/ &#8212;&nbsp;CSOFT Health Sciences, lea &#8230;<\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"pgc_sgb_lightbox_settings":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/posts\/152648"}],"collection":[{"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/comments?post=152648"}],"version-history":[{"count":0,"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/posts\/152648\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/media?parent=152648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/categories?post=152648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.csoftintl.com\/cn\/wp-json\/wp\/v2\/tags?post=152648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}